• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 May;27(5).
doi: 10.3201/eid2705.204056.
Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia

Abeer N Alshukairi, Jincun Zhao, Maha A Al-Mozaini, Yanqun Wang, Ashraf Dada, Salim A Baharoon, Sara Alfaraj, Waleed A Ahmed, Mushira A Enani, Fatehi E Elzein, Nazik Eltayeb, Laila Layqah, Aiman El-Saed, Husam A Bahaudden, Abdul Haseeb, Sherif A El-Kafrawy, Ahmed M Hassan, Najlaa A Siddiq, Ibtihaj Alsharif, Isamel Qushmaq, Esam I Azhar, Stanley Perlman, Ziad A Memish

Abstract

Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection.

Keywords: MERS; MERS-CoV; Middle East respiratory syndrome; Middle East respiratory syndrome coronavirus; Saudi Arabia; antibody responses; coronaviruses; disease severity; humans; longevity; patients; viruses; zoonoses.
 
Back
Top